Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2
Frondoside A, derived from the sea cucumber Cucumaria frondosa has demonstrable anticancer activity in several models, however, the ability of Frondoside A to affect tumor metastasis has not been reported. Using a syngeneic murine model of metastatic breast cancer, we now show that Frondoside A has potent antimetastatic activity. Frondoside A given i.p. to mice bearing mammary gland-implanted mammary tumors, inhibits spontaneous tumor metastasis to the lungs. The elevated Cyclooxygenase-2 activity in many malignancies promotes tumor growth and metastasis by producing high levels of PGE2 which acts on the prostaglandin E receptors, chiefly EP4 and EP2. We examined the ability of Frondoside A to modulate the functions of these EP receptors. We now show that Frondoside A antagonizes the prostaglandin E receptors EP2 and EP4. 3H-PGE2 binding to recombinant EP2 or EP4-expressing cells was inhibited by Frondoside A at low μM concentrations. Likewise, EP4 or EP2-linked activation of intracellular cAMP as well as EP4-mediated ERK1/2 activation were also inhibited by Frondoside A. Consistent with the antimetastatic activity observed in vivo, migration of tumor cells in vitro in response to EP4 or EP2 agonists was also inhibited by Frondoside A. These studies identify a new function for an agent with known antitumor activity, and show that the antimetastatic activity may be due in part to a novel mechanism of action. These studies add to the growing body of evidence that Frondoside A may be a promising new agent with potential to treat cancer and may also represent a potential new modality to antagonize EP4.
KeywordsFrondoside A Prostaglandin EP receptor EP4 EP2 Metastasis
- 1.Kalinin VI, Aminin DL, Avilov SA, Silchenko AS, Stonik VA (2008) Triterpene glycosides from sea cucumbers (Holothurioidea, Echinodermata). Biological activities and functions. In: Atta-ur-Rahman V (ed) Studies in natural product chemistry. Elsevier, The Netherlands, pp 135–196Google Scholar
- 5.Al Marzouqi N, Iratni R, Nemmar A, Arafat K, Al Sultan MAH, Collin P et al (2011) Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts. Eur J Pharmacol 651(1–3):18–25Google Scholar
- 6.Aminin DL, Agafonova IG, Kalinin VI, Silchenko AS, Avilov SA, Stonik VA, Collin PD, Woodward C (2008) Immunomodulatory properties of Frondoside A, a major triterpene glycoside from the North Atlantic commercially harvested sea cucumber Cucumaria frondosa. J Med Food 11:443–453PubMedCrossRefGoogle Scholar
- 19.Lee J, Banu SK, Subbarao T, Starzinski-Powitz A, Arosh JA (2011) Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases. Mol Cell Endocrinol 332:306–313PubMedCrossRefGoogle Scholar
- 22.Holt D, Ma X, Kundu N, Fulton A (2011) Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4. Cancer Immunol Immunother Google Scholar